Previous study has reported that 20–40% of GC patients are negative for CEA, CA19-9, and CA72-4 on account of the Lewis a-b- genotype, hence resulting in missed diagnosis (Guo et al, 2023). The gene discussed is CEACAM5; the disease is gastric cancer.